MEDICINOVA, INC. Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
MEDICINOVA, INC. (MNOV) had Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount of $600.00 thousand as of 2017-09-30, per its 10-Q filed 2017-10-23.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions · last filed 2017-10-23
- 2017-09-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $600.00K.
- 2017-06-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $1.90M.
- 2017-03-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $4.10M.
- 2016-09-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $2.00M.
| Period end | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount |
|---|---|
| 2017-09-30 | $600.00K 10-Q · filed 2017-10-23 |
| 2017-06-30 | $1.90M 10-Q · filed 2017-07-26 |
| 2017-03-31 | $4.10M 10-Q · filed 2017-04-26 |
| 2016-09-30 | $2.00M 10-Q · filed 2016-10-25 |
| 2016-06-30 | $1.10M 10-Q · filed 2016-07-26 |
| 2012-09-30 | $2.00M 10-Q · filed 2012-11-08 |
| 2012-06-30 | $1.30M 10-Q · filed 2012-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |